Effect of rikkunshito, a Japanese herbal medicine, on gastrointestinal symptoms and ghrelin levels in gastric cancer patients after gastrectomy

Gastric Cancer

Volumn 16, Issue 2, 2013, Pages 167-174

  Takiguchi, Shuji ^a   Hiura, Yuichiro ^a   Takahashi, Tsuyoshi ^a   Kurokawa, Yukinori ^a   Yamasaki, Makoto ^a   Nakajima, Kiyokazu ^a   Miyata, Hiroshi ^a   Mori, Masaki ^a   Hosoda, Hiroshi ^b   Kangawa, Kenji ^b   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Gastrectomy; Gastric cancer; Ghrelin; Rikkunshito

Indexed keywords

GHRELIN; HERBACEOUS AGENT; RIKKUNSHITO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATRACTYLODIS LANCEAE; AURANTII NOBILIS; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; DECREASED APPETITE; DRUG EFFECT; DRUG MIXTURE; DUMPING SYNDROME; FEMALE; GASTRECTOMY; GASTROINTESTINAL SYMPTOM; GINGER; GINSENG; GLYCYRRHIZA; HERB; HERBAL MEDICINE; HORMONE BLOOD LEVEL; HUMAN; JAPANESE; LAPAROSCOPIC SURGERY; MALE; NAUSEA AND VOMITING; PINELLIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH CANCER; SURGICAL APPROACH; TREATMENT DURATION; VISUAL ANALOG SCALE; ZIZYPHI;

AGED; APPETITE; DRUGS, CHINESE HERBAL; DUMPING SYNDROME; ESOPHAGITIS, PEPTIC; FEMALE; GHRELIN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; MEDICINE, EAST ASIAN TRADITIONAL; MIDDLE AGED; POSTGASTRECTOMY SYNDROMES; QUALITY OF LIFE; STOMACH NEOPLASMS;

EID: 84880702900     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0164-3     Document Type: Article

References (46)

1. Kakizoe T, Yamaguchi N, Mitsuhashi F, et al. Cancer statistics in Japan 2001. Tokyo: Foundation for Promotion of Cancer Research; 2001.
2. Okabayashi T, Gotoda T, Kondo H, et al. Early carcinoma of the gastric cardia in Japan: is it different from that in the West? Cancer. 2000;89:2555-9.
3. Hioki K, Nakane Y, Yamamoto Y, et al. Surgical strategy for early gastric cancer. Br J Surg. 1990;77:1330-40.
4. Sawai K, Takahashi T, Suzuki H. New trends in surgery for gastric cancer in Japan. J Surg Oncol. 1994;56:221-6.
5. Calman KC. Quality of life in cancer patients: a hypothesis. J Med Ethics. 1984;10:124-7.
6. Blazeby JM. The role of quality of life assessment in gastric cancer. Jpn J Clin Oncol. 2000;30:246.
7. Kaptein AA, Morita S, Sakamoto J. Quality of life in gastric cancer. World J Gastroenterol. 2005;11:3189-96.
8. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-60.
9. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-8.
10. Van der Lely AJ, Tschop M, Heiman ML, et al. Biological physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25:426-57.
11. Ariyasu H, Iwakura H, Yamada G, et al. Efficacy of ghrelin as a therapeutic approach for age related physiological changes. Endocrinology. 2008;149:3722-8.
12. Akamizu T, Kangawa K. Translational research on the clinical applications of ghrelin. Endocr J. 2006;53:585-91.
13. Adachi S, Takiguchi S, Okada K, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138:1312-20.
14. Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery. 2010;141:31-8.
15. Matsumura T, Arai M, Yonemitsu Y, et al. The traditional Japanese medicine rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol. 2010;45:300-7.
16. Takeda H, Sadakane C, Hattori T, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008;134:2004-13.
17. Tatsuta A, Ishii H. Effect of treatment with Lin-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther. 1993;7:459-62.
18. Oka T, Tamagawa Y, Tamagawa Y, et al. Rikkunshito attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsychosoc Med. 2007;15:1-21.
19. Kawahara H, Kubota A, Hasegawa T, et al. Effect of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux. Pediatr Surg Int. 2007;23:1001-5.
20. Kawahara H, Mitani Y, Nomura M, et al. Impact of rikkunshito, an herbal medicine, on delayed gastric emptying in profoundly handicapped patients. Pediatr Surg Int. 2009;25:987-90.
21. Yagi M, Homma S, Kubota M, et al. The herbal medicine rikkunshito stimulates and coordinates the gastric myoelectric activity in post-operative dyspeptic children after gastrointestinal surgery. Pediatr Surg Int. 2004;19:760-5.
22. Takahashi T, Endo S, Nakajima K, Souma Y, Nishida T. Effect of rikkunshito, a Chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy. World J Surg. 2009;33:296-302.
23. Tomono H, Ito Y, Watanabe T. Successful antiemetic treatment of TSUMURA rikkunshito extract granules for ethical use in additional to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Gan To Kagaku Ryoho. 2006;33:1129-31.
24. Kido T, Nakai Y, Kase Y, et al. Effects of rikkunshito, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-l-arginine. J Pharmacol Sci. 2005;98:161-7.
25. Takiguchi S, Yamamoto K, Hirao M, et al. A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer. 2012;15(2):198-205.
26. Tominaga K, Kido T, Ochi M, et al. The traditional Japanese medicine rikkunshito promotes gastric emptying via the antagonistic action of the 5-HT3 receptor pathway in rats. Evid Based Complement Altern Med. 2009. doi: 10.1093/ecam/nep173
27. Nakamura M, Hosoya Y, Yano M, et al. Extent of gastric resection impacts patient quality of life: the Dysfunction after Upper Gastrointestinal Surgery for Cancer (DAUGS32) scoring system. Ann Surg Oncol. 2011;18:314-20.
28. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-76.
29. Akamizu T, Shinomiya T, Irako T, et al. Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab. 2005;90:6-9.
30. Kusunoki H, Haruma K, Hata J, et al. Efficacy of rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med. 2010;49:2195-202.
31. Goso Y, Ogata Y, Ishihara K, et al. Effects of traditional herbal medicine on gastric mucin against ethanol-induced gastric injury in rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996;113:17-21.
32. Miwa H, Koseki J, Oshima T, et al. Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. J Gastroenterol. 2010;45:478-87.
33. Fujitsuka N, Asakawa A, Hayashi M, et al. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry. 2009;65:748-59.
34. Takachi K, Doki Y, Ishikawa O, et al. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res. 2006;130:1-7.
35. Hosoda H, Kojima K, Mizushima T, et al. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem. 2003;278:64-70.
36. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tract of rats and humans. Endocrinology. 2000;141:4255-61.
37. Hiejima H, Nishi Y, Hosoda H, et al. Regional distribution and the dynamics of n-decanoyl ghrelin, another acyl-form of ghrelin, upon fasting in rodents. Regul Pept. 2009;156:47-56.
38. Sadakane C, Muto S, Nakagawa K, et al. 10-Gingerol, a component of rikkunshito, improves cisplatin-induced anorexia by inhibiting acylated ghrelin degradation. Biochem Biophys Res Commun. 2011;2(412):506-11.
39. Hashimoto K, Kase Y, Murata P, et al. Pharmacological evaluation of Shokyo and Kankyo (1). Biol Pharm Bull. 2002;25:1183-7.
40. Nakabayashi T, Mochiki E, Kamiyama Y, et al. Erythromycin induces pyloric relaxation accompanied by a contraction of the gastric body after pylorus-preserving gastrectomy. Surgery. 2003;133:647-55.
41. Abell TL, Camilleri M, DiMagno EP, et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci. 1991;36:616-20.
42. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol. 1997;92:976-80.
43. Loo FD, Palmer DW, Soergel KH, et al. Gastric emptying in patients with diabetes mellitus. Gastroenterology. 1984;86:485-94.
44. Koch KL, Stern RM, Stewart WR, et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol. 1989;84:1069-75.
45. Riezzo G, Cucchiara S, Chiloiro M, et al. Gastric emptying and myoelectrical activity in children with non-ulcer dyspepsia. Effect of cisapride. Dig Dis Sci. 1995;40:1428-34.
46. Hayakawa T, Arakawa T, Kase Y, et al. Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res. 1999;25:211-8.